Dipan Mehta of Elixir Equities notes a mixed earnings season with disappointments in major sectors like banking and software. However, urban consumption shows promising signs in QSR, retail, hospitality, healthcare, and travel. Mehta advises selectivity, favoring pharma companies with differentiated models, particularly CDMOs, while remaining cautious due to potential tariff impacts and base effects.
IRDAI clears investments in private companies, eases infrastructure funding norms
IRDAI has expanded insurers’ investment options by permitting investments in private limited companies, infrastructure SPV debt and repo, reverse repo and government securities lending transactions.
August 1, 2026